Literature DB >> 16413649

Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.

Stephanie Simon1, Stefan O Mueller.   

Abstract

The androgen receptor (AR) is a member of the nuclear receptor superfamily and mediates the physiological effects of androgens. Androgens are essential for male development and disruption of androgen signaling may cause androgen-dependent developmental defects and/or tumors. Here we present a comparative analysis of various model systems for the investigation of endocrine active compounds in human cell lines. We generated reporter plasmids containing androgen response elements derived from the human secretory component or the rat probasin genes as well as the glucocorticoid consensus response element and compared their activities to that of the mouse mammary tumor virus promotor. Additionally, we generated an expression plasmid containing the AR cDNA derived from LNCaP cells. In 22Rv1 cells transiently transfected with human AR, all reporters displayed a dose-dependent, high activity when treated with androgens. Interestingly, the potency of testosterone and its metabolite dihydrotestosterone was very low in HepG2 but not in 22Rv1 cells, independent of the reporter used. The efficacies of the androgens tested were comparable in both cell lines but highly dependent on the reporter used. Based on these results, 22Rv1 cells provide a highly sensitive in vitro test system to analyze endocrine activities of xenobiotics. Furthermore, this study highlights the need to investigate the (anti-) androgenic activity of compounds in dependence of the cellular and promoter context.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413649     DOI: 10.1016/j.tox.2005.12.002

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  4 in total

1.  A multifunctional androgen receptor screening assay using the high-throughput Hypercyt flow cytometry system.

Authors:  Megan K Dennis; Harmony J C Bowles; Debra A MacKenzie; Scott W Burchiel; Bruce S Edwards; Larry A Sklar; Eric R Prossnitz; Todd A Thompson
Journal:  Cytometry A       Date:  2008-05       Impact factor: 4.355

2.  New single nucleotide variation in the promoter region of androgen receptor (AR) gene in hypospadic patients.

Authors:  Nasim Borhani; Marefat Ghaffari Novin; Mehdi Manoochehri; Mohsen Rouzrokh; Bahram Kazemi; Ameneh Koochaki; Ahmad Hosseini; Reza Masteri Farahani; Mir Davood Omrani
Journal:  Iran J Reprod Med       Date:  2014-03

3.  Predicting puberty in partial androgen insensitivity syndrome: Use of clinical and functional androgen receptor indices.

Authors:  Ngee Lek; Rieko Tadokoro-Cuccaro; Jonathan B Whitchurch; Bismoy Mazumder; Harriet Miles; Philippa Prentice; Trevor Bunch; Karolina Zielińska; Veronika Metzler; Nigel P Mongan; David M Heery; Ieuan A Hughes
Journal:  EBioMedicine       Date:  2018-10-11       Impact factor: 8.143

4.  Diastereomers of the brominated flame retardant 1,2-dibromo-4-(1,2 dibromoethyl)cyclohexane induce androgen receptor activation in the hepg2 hepatocellular carcinoma cell line and the lncap prostate cancer cell line.

Authors:  Hazem Khalaf; Anders Larsson; Håkan Berg; Robert McCrindle; Gilles Arsenault; Per-Erik Olsson
Journal:  Environ Health Perspect       Date:  2009-08-03       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.